Exosomes derived from HIV-1-infected cells contain trans-activation response element RNA

Journal of Biological Chemistry

Volumn 288, Issue 27, 2013, Pages 20014-20033

  Narayanan, Aarthi ^a   Iordanskiy, Sergey ^a,b   Das, Ravi ^a   Van Duyne, Rachel ^a,b   Santos, Steven ^b   Jaworski, Elizabeth ^a   Guendel, Irene ^a   Sampey, Gavin ^a   Dalby, Elizabeth ^a   Iglesias Ussel, Maria ^c   Popratiloff, Anastas ^b   Hakami, Ramin ^a   Kehn Hall, Kylene ^a   Young, Mary ^d   Subra, Caroline ^e   Gilbert, Caroline ^e   Bailey, Charles ^a   Romerio, Fabio ^c   Kashanchi, Fatah ^a  

^a GEORGE MASON UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^e LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL DEATH; CHEMICAL ACTIVATION; DISEASES; GENE EXPRESSION; MACHINERY; PATIENT TREATMENT; PROTEINS; TAR; VIRUSES;

ACTIVE PROCESS; HIGHLY ACTIVE ANTI-RETROVIRAL THERAPIES; HIV-1 INFECTIONS; INFECTED CELLS; NANO SIZED; SUPERNATANTS; TRANS-ACTIVATION RESPONSE; VIRUS-INFECTED CELLS;

RNA;

BIM PROTEIN; CYCLIN DEPENDENT KINASE 9; DICER; DROSHA PROTEIN; MICRORNA; SMALL UNTRANSLATED RNA; TRANSACTIVATION RESPONSE ELEMENT RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL NUCLEUS; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; EXOSOME; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOPRECIPITATION; INFECTION SENSITIVITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSPORT; SERUM; TRANSMISSION ELECTRON MICROSCOPY; VIRUS CELL INTERACTION;

EID: 84880065053     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.438895     Document Type: Article

References (93)

1. Mathivanan, S., Ji, H., and Simpson, R. J. (2010) Exosomes: extracellular organelles important in intercellular communication. J. Proteomics 73, 1907-1920
2. Denzer, K., Kleijmeer, M. J., Heijnen, H. F., Stoorvogel, W., and Geuze, H. J. (2000) Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J. Cell Sci. 113, 3365-3374
3. Stoorvogel, W., Kleijmeer, M. J., Geuze, H. J., and Raposo, G. (2002) The biogenesis and functions of exosomes. Traffic 3, 321-330
4. Booth, A. M., Fang, Y., Fallon, J. K., Yang, J. M., Hildreth, J. E., and Gould, S. J. (2006) Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. J. Cell Biol. 172, 923-935
5. Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., and Lötvall, J. O. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659
6. Eldh, M., Ekström, K., Valadi, H., Sjöstrand, M., Olsson, B., Jernås, M., and Lötvall, J. (2010) Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA. PLoS One 5, e15353
7. Simpson, R. J., Lim, J. W., Moritz, R. L., and Mathivanan, S. (2009) Exosomes: proteomic insights and diagnostic potential. Expert Rev. Proteomics 6, 267-283
8. Rana, S., and Zöller, M. (2011) Exosome target cell selection and the importance of exosomal tetraspanins: a hypothesis. Biochem. Soc. Trans. 39, 559-562
9. Wang, Z., Hill, S., Luther, J. M., Hachey, D. L., and Schey, K. L. (2012) Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT). Proteomics 12, 329-338
10. Dimov, I., Jankovic Velickovic, L., and Stefanovic, V. (2009) Urinary exosomes. Scientific World Journal 9, 1107-1118
11. Ludwig, A. K., and Giebel, B. (2012) Exosomes: small vesicles participating in intercellular communication. Int. J. Biochem. Cell Biol. 44, 11-15
12. Anand, P. K. (2010) Exosomal membrane molecules are potent immune response modulators. Commun. Integr. Biol. 3, 405-408
13. Record, M., Subra, C., Silvente-Poirot, S., and Poirot, M. (2011) Exosomes as intercellular signalosomes and pharmacological effectors. Biochem. Pharmacol. 81, 1171-1182
14. Théry, C., Ostrowski, M., and Segura, E. (2009) Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9, 581-593
15. Simons, M., and Raposo, G. (2009) Exosomes-vesicular carriers for intercellular communication. Curr. Opin. Cell Biol. 21, 575-581
16. Duijvesz, D., Luider, T., Bangma, C. H., and Jenster, G. (2011) Exosomes as biomarker treasure chests for prostate cancer. Eur. Urol. 59, 823-831
17. Agrawal, N., Dasaradhi, P. V., Mohmmed, A., Malhotra, P., Bhatnagar, R. K., and Mukherjee, S. K. (2003) RNA interference: biology, mechanism, and applications. Microbiol. Mol. Biol. Rev. 67, 657-685
18. Geanacopoulos, M. (2005) An introduction to RNA-mediated gene silencing. Sci. Prog. 88, 49-69
19. Grishok, A. (2005) RNAi mechanisms in Caenorhabditis elegans. FEBS Lett. 579, 5932-5939
20. Montgomery, M. K. (2004) RNA interference: historical overview and significance. Methods Mol. Biol. 265, 3-21
21. Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297
22. Chendrimada, T. P., Gregory, R. I., Kumaraswamy, E., Norman, J., Cooch, N., Nishikura, K., and Shiekhattar, R. (2005) TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436, 740-744
23. Ghildiyal, M., and Zamore, P. D. (2009) Small silencing RNAs: an expanding universe. Nat. Rev. Genet. 10, 94-108
24. Winter, J., Jung, S., Keller, S., Gregory, R. I., and Diederichs, S. (2009) Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 11, 228-234
25. Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Rådmark, O., Kim, S., and Kim, V. N. (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415-419
26. Perron, M. P., and Provost, P. (2008) Protein interactions and complexes in human microRNA biogenesis and function. Front. Biosci. 13, 2537-2547
27. Perron, M. P., and Provost, P. (2009) Protein components of the microRNA pathway and human diseases. Methods Mol. Biol. 487, 369-385
28. Naqvi, A. R., Islam, M. N., Choudhury, N. R., and Haq, Q. M. (2009) The fascinating world of RNA interference. Int. J. Biol. Sci. 5, 97-117
29. Lejeune, E., and Allshire, R. C. (2011) Common ground: small RNA programming and chromatin modifications. Curr. Opin. Cell Biol. 23, 258-265
30. Verdel, A., Jia, S., Gerber, S., Sugiyama, T., Gygi, S., Grewal, S. I., and Moazed, D. (2004) RNAi-mediated targeting of heterochromatin by the RITS complex. Science 303, 672-676
31. Zofall, M., and Grewal, S. I. (2006) RNAi-mediated heterochromatin assembly in fission yeast. Cold Spring Harbor Symp. Quant. Biol. 71, 487-496
32. de Vries, W., and Berkhout, B. (2008) RNAi suppressors encoded by pathogenic human viruses. Int. J. Biochem. Cell Biol. 40, 2007-2012
33. Haasnoot, J., and Berkhout, B. (2011) RNAi and cellular miRNAs in infections by mammalian viruses. Methods Mol. Biol. 721, 23-41
34. Schütz, S., and Sarnow, P. (2006) Interaction of viruses with the mammalian RNA interference pathway. Virology 344, 151-157
35. van Rij, R. P., and Andino, R. (2006) The silent treatment: RNAi as a defense against virus infection in mammals. Trends Biotechnol. 24, 186-193
36. Bivalkar-Mehla, S., Vakharia, J., Mehla, R., Abreha, M., Kanwar, J. R., Tikoo, A., and Chauhan, A. (2011) Viral RNA silencing suppressors (RSS): novel strategy of viruses to ablate the host RNA interference (RNAi) defense system. Virus Res. 155, 1-9
37. Scaria, V., Hariharan, M., Maiti, S., Pillai, B., and Brahmachari, S. K. (2006) Host-virus interaction: a new role for microRNAs. Retrovirology 3, 68
38. Boss, I. W., Plaisance, K. B., and Renne, R. (2009) Role of virus-encoded microRNAs in herpesvirus biology. Trends Microbiol. 17, 544-553
39. Dölken, L., Pfeffer, S., and Koszinowski, U. H. (2009) Cytomegalovirus microRNAs. Virus Genes 38, 355-364
40. Grundhoff, A., Sullivan, C. S., and Ganem, D. (2006) A combined computational and microarray-based approach identifies novel microRNAs encoded by human γ-herpesviruses. RNA 12, 733-750
41. Nair, V., and Zavolan, M. (2006) Virus-encoded microRNAs: novel regulators of gene expression. Trends Microbiol. 14, 169-175
42. Plaisance-Bonstaff, K., and Renne, R. (2011) Viral miRNAs. Methods Mol. Biol. 721, 43-66
43. Zhu, J. Y., Pfuhl, T., Motsch, N., Barth, S., Nicholls, J., Grässer, F., and Meister, G. (2009) Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J. Virol. 83, 3333-3341
44. Pfeffer, S., Sewer, A., Lagos-Quintana, M., Sheridan, R., Sander, C., Grässer, F. A., van Dyk, L. F., Ho, C. K., Shuman, S., Chien, M., Russo, J. J., Ju, J., Randall, G., Lindenbach, B. D., Rice, C. M., Simon, V., Ho, D. D., Zavolan, M., and Tuschl, T. (2005) Identification of microRNAs of the herpesvirus family. Nat. Methods 2, 269-276
45. Lin, J., and Cullen, B. R. (2007) Analysis of the interaction of primate retroviruses with the human RNA interference machinery. J. Virol. 81, 12218-12226
46. Klase, Z., Kale, P., Winograd, R., Gupta, M. V., Heydarian, M., Berro, R., McCaffrey, T., and Kashanchi, F. (2007) HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. BMC Mol. Biol. 8, 63
47. Narayanan, A., Kehn-Hall, K., Bailey, C., and Kashanchi, F. (2011) Analysis of the roles of HIV-derived microRNAs. Expert Opin. Biol. Ther. 11, 17-29
48. Klase, Z., Winograd, R., Davis, J., Carpio, L., Hildreth, R., Heydarian, M., Fu, S., McCaffrey, T., Meiri, E., Ayash-Rashkovsky, M., Gilad, S., Bentwich, Z., and Kashanchi, F. (2009) HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology 6, 18
49. Yeung, M. L., Bennasser, Y., Watashi, K., Le, S. Y., Houzet, L., and Jeang, K. T. (2009) Pyrosequencing of small noncoding RNAs in HIV-1-infected cells: evidence for the processing of a viral-cellular double-stranded RNA hybrid. Nucleic Acids Res. 37, 6575-6586
50. Ouellet, D. L., Plante, I., Landry, P., Barat, C., Janelle, M. E., Flamand, L., Tremblay, M. J., and Provost, P. (2008) Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element. Nucleic Acids Res. 36, 2353-2365
51. Lamers, S. L., Fogel, G. B., and McGrath, M. S. (2010) HIV-miR-H1 evolvability during HIV pathogenesis. Biosystems 101, 88-96
52. Omoto, S., Ito, M., Tsutsumi, Y., Ichikawa, Y., Okuyama, H., Brisibe, E. A., Saksena, N. K., and Fujii, Y. R. (2004) HIV-1 Nef suppression by virally encoded microRNA. Retrovirology 1, 44
53. Schopman, N. C., Willemsen, M., Liu, Y. P., Bradley, T., van Kampen, A., Baas, F., Berkhout, B., and Haasnoot, J. (2012) Deep sequencing of virusinfected cells reveals HIV-encoded small RNAs. Nucleic Acids Res. 40, 414-427
54. Klase, Z., Houzet, L., and Jeang, K. T. (2011) Replication competent HIV-1 viruses that express intragenomic microRNA reveal discrete RNA-interference mechanisms that affect viral replication. Cell Biosci. 1, 38
55. Pegtel, D. M., Cosmopoulos, K., Thorley-Lawson, D. A., van Eijndhoven, M. A., Hopmans, E. S., Lindenberg, J. L., de Gruijl, T. D., Würdinger, T., and Middeldorp, J. M. (2010) Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. U.S.A. 107, 6328-6333
56. Pegtel, D. M., van de Garde, M. D., and Middeldorp, J. M. (2011) Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular cross-talk and immune evasion. Biochim. Biophys. Acta 1809, 715-721
57. Zomer, A., Vendrig, T., Hopmans, E. S., van Eijndhoven, M., Middeldorp, J. M., and Pegtel, D. M. (2010) Exosomes: Fit to deliver small RNA. Commun. Integr. Biol. 3, 447-450
58. Barth, S., Meister, G., and Grässer, F. A. (2011) EBV-encoded miRNAs. Biochim Biophys Acta 1809, 631-640
59. Gourzones, C., Gelin, A., Bombik, I., Klibi, J., Vérillaud, B., Guigay, J., Lang, P., Témam, S., Schneider, V., Amiel, C., Baconnais, S., Jimenez, A. S., and Busson, P. (2010) Extracellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells. Virol. J. 7, 271
60. Campbell, T. D., Khan, M., Huang, M. B., Bond, V. C., and Powell, M. D. (2008) HIV-1 Nef protein is secreted into vesicles that can fuse with target cells and virions. Ethn. Dis. 18, S2-14-19
61. Lenassi, M., Cagney, G., Liao, M., Vaupotic, T., Bartholomeeusen, K., Cheng, Y., Krogan, N. J., Plemenitas, A., and Peterlin, B. M. (2010) HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic 11, 110-122
62. Ali, S. A., Huang, M. B., Campbell, P. E., Roth, W. W., Campbell, T., Khan, M., Newman, G., Villinger, F., Powell, M. D., and Bond, V. C. (2010) Genetic characterization of HIV type 1 Nef-induced vesicle secretion. AIDS Res. Hum. Retroviruses 26, 173-192
63. Muratori, C., Cavallin, L. E., Krätzel, K., Tinari, A., De Milito, A., Fais, S., D'Aloja, P., Federico, M., Vullo, V., Fomina, A., Mesri, E. A., Superti, F., and Baur, A. S. (2009) Massive secretion by T cells is caused by HIV Nef in infected cells and by Nef transfer to bystander cells. Cell Host Microbe 6, 218-230
64. Shelton, M. N., Huang, M. B., Ali, S. A., Powell, M. D., and Bond, V. C. (2012) Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release. J. Virol. 86, 406-419
65. Fang, Y., Wu, N., Gan, X., Yan, W., Morrell, J. C., and Gould, S. J. (2007) Higher order oligomerization targets plasma membrane proteins and HIV Gag to exosomes. PLoS Biol. 5, e158
66. Gan, X., and Gould, S. J. (2011) Identification of an inhibitory budding signal that blocks the release of HIV particles and exosome/microvesicle proteins. Mol. Biol. Cell 22, 817-830
67. Shen, B., Wu, N., Yang, J. M., and Gould, S. J. (2011) Protein targeting to exosomes/microvesicles by plasma membrane anchors. J. Biol. Chem. 286, 14383-14395
68. Van Duyne, R., Guendel, I., Kehn-Hall, K., Easley, R., Klase, Z., Liu, C., Young, M., and Kashanchi, F. (2010) The identification of unique serum proteins of HIV-1 latently infected long-term nonprogressor patients. AIDS Res. Ther. 7, 21
69. Cantin, R., Diou, J., Bélanger, D., Tremblay, A. M., and Gilbert, C. (2008) Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants. J. Immunol. Methods 338, 21-30
70. Carpio, L., Klase, Z., Coley, W., Guendel, I., Choi, S., Van Duyne, R., Narayanan, A., Kehn-Hall, K., Meijer, L., and Kashanchi, F. (2010) Erratum to: microRNA machinery is an integral component of drug-induced transcription inhibition in HIV-1 infection. J. RNAi Gene Silencing 6, E386
71. Carpio, L., Klase, Z., Coley, W., Guendel, I., Choi, S., Van Duyne, R., Narayanan, A., Kehn-Hall, K., Meijer, L., and Kashanchi, F. (2010) microRNA machinery is an integral component of drug-induced transcription inhibition in HIV-1 infection. J. RNAi Gene Silencing 6, 386-400
72. Easley, R., Carpio, L., Dannenberg, L., Choi, S., Alani, D., Van Duyne, R., Guendel, I., Klase, Z., Agbottah, E., Kehn-Hall, K., and Kashanchi, F. (2010) Transcription through the HIV-1 nucleosomes: effects of the PBAF complex in Tat activated transcription. Virology 405, 322-333
73. Marini, A., Harper, J. M., and Romerio, F. (2008) An in vitro system to model the establishment and reactivation of HIV-1 latency. J. Immunol. 181, 7713-7720
74. Arroyo, J. D., Chevillet, J. R., Kroh, E. M., Ruf, I. K., Pritchard, C. C., Gibson, D. F., Mitchell, P. S., Bennett, C. F., Pogosova-Agadjanyan, E. L., Stirewalt, D. L., Tait, J. F., and Tewari, M. (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. U.S.A. 108, 5003-5008
75. Turchinovich, A., Weiz, L., Langheinz, A., and Burwinkel, B. (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res. 39, 7223-7233
76. Zou, S., El-Hage, N., Podhaizer, E. M., Knapp, P. E., and Hauser, K. F. (2011) PTEN gene silencing prevents HIV-1 gp120(IIIB)-induced degeneration of striatal neurons. J. Neurovirol. 17, 41-49
77. Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., and Wood, M. J. (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29, 341-345
78. Bentham, M., Mazaleyrat, S., and Harris, M. (2006) Role of myristoylation and N-terminal basic residues in membrane association of the human immunodeficiency virus type 1 Nef protein. J. Gen. Virol. 87, 563-571
79. Boucheix, C., and Rubinstein, E. (2001) Tetraspanins. Cell. Mol. Life Sci. 58, 1189-1205
80. Charrin, S., le Naour, F., Silvie, O., Milhiet, P. E., Boucheix, C., and Rubinstein, E. (2009) Lateral organization of membrane proteins: tetraspanins spin their web. Biochem. J. 420, 133-154
81. Yunta, M., and Lazo, P. A. (2003) Tetraspanin proteins as organisers of membrane microdomains and signalling complexes. Cell. Signal. 15, 559-564
82. Pols, M. S., and Klumperman, J. (2009) Trafficking and function of the tetraspanin CD63. Exp. Cell Res. 315, 1584-1592
83. Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., Schwille, P., Brügger, B., and Simons, M. (2008) Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319, 1244-1247
84. Bröcker, C., Engelbrecht-Vandré, S., and Ungermann, C. (2010) Multisubunit tethering complexes and their role in membrane fusion. Curr. Biol. 20, R943-R952
85. Coley, W., Van Duyne, R., Carpio, L., Guendel, I., Kehn-Hall, K., Chevalier, S., Narayanan, A., Luu, T., Lee, N., Klase, Z., and Kashanchi, F. (2010) Absence of DICER in monocytes and its regulation by HIV-1. J. Biol. Chem. 285, 31930-31943
86. Brandano, L., and Stevenson, M. (2012) A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particles. J. Virol. 86, 2347-2359
87. Furnes, C., Andresen, V., and Szilvay, A. M. (2008) Functional rescue of an oligomerization-defective HIV-1 Rev mutant by fusion with an oligomeric tag. Arch. Virol. 153, 357-362
88. Mohammed, K. D., Topper, M. B., and Muesing, M. A. (2011) Sequential deletion of the integrase (Gag-Pol) carboxyl terminus reveals distinct phenotypic classes of defective HIV-1. J. Virol. 85, 4654-4666
89. Paolucci, S., Gulminetti, R., Maserati, R., Dossena, L., and Baldanti, F. (2011) Accumulation of defective HIV-1 variants in a patient with slow disease progression. Curr. HIV Res. 9, 17-22
90. Poe, J. A., and Smithgall, T. E. (2009) HIV-1 Nef dimerization is required for Nef-mediated receptor down-regulation and viral replication. J. Mol. Biol. 394, 329-342
91. Sandonís, V., Casado, C., Alvaro, T., Pernas, M., Olivares, I., García, S., Rodríguez, C., del Romero, J., and López-Galíndez, C. (2009) A combination of defective DNA and protective host factors are found in a set of HIV-1 ancestral LTNPs. Virology 391, 73-82
92. Venkatachari, N. J., Walker, L. A., Tastan, O., Le, T., Dempsey, T. M., Li, Y., Yanamala, N., Srinivasan, A., Klein-Seetharaman, J., Montelaro, R. C., and Ayyavoo, V. (2010) Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles. Virol. J. 7, 119
93. Wang, S. H., Xing, H., He, X., Zhu, F. X., Meng, Z. F., Ruan, Y. H., and Shao, Y. M. (2008) Nef mutations in long-term nonprogressors from former plasma donors infected with HIV-1 subtype B in China. Biomed. Environ. Sci. 21, 485-491